Recall · openFDA Food Enforcement

Klaire Labs Reduced L-Glutathione 150 mg capsules, single…: FDA Recall F-1186-2019

Agency action: Dec 13, 2018Record ID: F-1186-2019
View official source ↗

What happened

Original notice title

Klaire Labs Reduced L-Glutathione 150 mg capsules, single capsule dose 100 vegetarian capsules SKU V799-10 UPC Code: 7 09616 79910 9, recall F-1186-2019

From the archived source record

Mis-packaging; product is labeled as Reduce L-Glutathione but actually contains Lithium Orotate.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Terminated
FDA recall classification
Class II
Recall initiated by
Voluntary: Firm initiated
Report date
Apr 3, 2019
Termination date in the archive
Apr 2, 2019
Source checked
Jul 16, 2026
Record revision
fcc92c99a922

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Klaire Labs Reduced L-Glutathione 150 mg capsules, single capsule dose 100 vegetarian capsules SKU V799-10 UPC Code: 7 09616 79910 9
Company
ProThera, Inc. dba SFI USA
Lot / identifier
FG Lot: 2018210303 Expiration: 05/2020
Market / distribution
US distribution to the following: AL, AZ, CA, KS, LA, MI, MO, NH, NJ, NY, OR, PA, TX, and WA Foreign distribution to the following: Netherlands, Great Britain, and Korea